Invention Grant
US09173890B2 Sustained release of Apo A-I mimetic peptides and methods of treatment
有权
持续释放Apo A-I模拟肽和治疗方法
- Patent Title: Sustained release of Apo A-I mimetic peptides and methods of treatment
- Patent Title (中): 持续释放Apo A-I模拟肽和治疗方法
-
Application No.: US11946028Application Date: 2007-11-27
-
Publication No.: US09173890B2Publication Date: 2015-11-03
- Inventor: Katsuyuki Murase , Jinping Wan , John Stankus , Dariush Davalian , Florian Ludwig
- Applicant: Katsuyuki Murase , Jinping Wan , John Stankus , Dariush Davalian , Florian Ludwig
- Applicant Address: US CA Santa Clara
- Assignee: Abbott Cardiovascular Systems Inc.
- Current Assignee: Abbott Cardiovascular Systems Inc.
- Current Assignee Address: US CA Santa Clara
- Agency: Blakely Sokoloff Taylor & Zafman LLP
- Agent Randy Shen, Esq.
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K31/661 ; A61K9/14 ; A61K38/10 ; A61K38/17 ; A61P3/00 ; A61K9/00 ; A61K9/127 ; A61K9/16 ; A61K9/51

Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.
Public/Granted literature
- US20090081293A1 SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT Public/Granted day:2009-03-26
Information query
IPC分类: